✦ LIBER ✦

Cytomegalovirus affects clinical outcome of infliximab in ulcerative colitis refractory to tacrolimus

✍ Scribed by H. Nakase; S. Yamamoto; M. Matsuura; Y. Honzawa; T. Chiba

Book ID: 108605994
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 53 KB
Volume: 32
Category: Article
ISSN: 0269-2813
DOI: 10.1111/j.1365-2036.2010.04372.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of infliximab as res

Efficacy and safety of infliximab as rescue therapy for ulcerative colitis refractory to tacrolimus

✍ Shuji Yamamoto; Hiroshi Nakase; Minoru Matsuura; Yusuke Honzawa; Satohiro Masuda 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 157 KB

Infliximab for the treatment of ulcerati

Infliximab for the treatment of ulcerative colitis: outcomes in Oxford from 2000 to 2006

✍ S. L. JAKOBOVITS; D. P. JEWELL; S. P. L. TRAVIS 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 477 KB

Usefulness of quantitative real-time PCR

Usefulness of quantitative real-time PCR assay for early detection of cytomegalovirus infection in patients with ulcerative colitis refractory to immunosuppressive therapies

✍ Takuya Yoshino; Hiroshi Nakase; Satoru Ueno; Norimitsu Uza; Satoko Inoue; Sakae 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB

Background: Studies suggest that cytomegalovirus (CMV) infection exacerbates ulcerative colitis (UC) refractory to immunosuppressive therapies. Early and accurate diagnosis of CMV infection is important for the treatment of UC. We evaluated the usefulness of quantitative real-time polymerase chain r

TNF-α is an important pathogenic factor

TNF-α is an important pathogenic factor contributing to reactivation of cytomegalovirus in inflamed mucosa of colon in patients with ulcerative colitis: Lesson from clinical experience

✍ Hiroshi Nakase; Tsutomu Chiba 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 44 KB